Starsource Multitrade Limited, formerly Chemo Pharma Laboratories Limited, is an India-based company. The Company was engaged in manufacturing operations. It has no operations and does not generate any revenue. The Company is exploring new business opportunities.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
26-07-17	₹81.00	+0.91%	865
26-07-16	₹80.27	-3.91%	225
26-07-15	₹83.54	-4.65%	1,828
26-07-14	₹87.61	-4.93%	734
26-07-13	₹92.15	-4.99%	571

Delayed Quote Bombay S.E.

More quotes

Income Statement and Estimates

More financial data

Market Closed - Bombay S.E. Other stock markets 06:00:57 2026-07-17 am EDT			5-day change	1st Jan Change
81.00 ^INR	+0.91%		-16.49%	-29.38%

May. 29	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
Feb. 12	Starsource Multitrade Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Market Cap	167M 1.73M 1.51M 1.4M 1.29M 2.43M 2.48M 16.7M 6.57M 81.71M 6.51M 6.36M 281M	P/E 2024	8.12x	P/E 2025	54.6x
Enterprise Value	60.62M 629K 550K 508K 468K 882K 901K 6.07M 2.39M 29.69M 2.36M 2.31M 102M	EV / Sales 2024	1.98x	EV / Sales 2025	13x
Free-Float	61.29%	Yield 2024 *	-	Yield 2025	-

May. 29	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
Feb. 12	Starsource Multitrade Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
Nov. 13	Starsource Multitrade Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-10-01	Chemo Pharma Laboratories Limited has Changed its Name to Starsource Multitrade Limited	CI
25-09-25	Chemo Pharma Laboratories Limited Announces Changes to Its Board	CI
25-09-25	Chemo Pharma Laboratories Limited Appoints and Regularize Utsav Trivedi as CFO	CI
25-09-25	Chemo Pharma Laboratories Limited Appoints and Regularize Ruchit Mehta as Chief Executive Officer	CI
25-09-12	Chemo Pharma Laboratories Limited Announces Company Secretary and Compliance Officer, Effective from September 12, 2025	CI
25-08-12	Chemo Pharma Laboratories Limited Decides to Shift the Registered Office	CI
25-08-12	Chemo Pharma Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-05-29	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
25-05-27	Chemo Pharma Laboratories to Open New Corporate Office in Ahmedabad, India; Shares Down 4%	MT
25-04-23	Chemo Pharma Laboratories Limited Approves the Appointment of Bhawna Rajput as Company Secretary and Compliance Officer, Effective 16 April, 2025	CI

1 day	+0.91%
1 week	-16.49%
Current month	-5.43%
1 month	-22.49%
3 months	-30.47%
6 months	-44.43%
Current year	-29.38%

Starsource Multitrade Limited Stock

Stocks

CHEMOPH6

INE320M01019

Investment Holding Companies

Valuation: Starsource Multitrade Limited

Chart: Starsource Multitrade Limited

Latest news : Starsource Multitrade Limited

Quotes and Performance

Course Extremes

Managers and Directors: Starsource Multitrade Limited

Shell Companies

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	80	92.16
1 month	76.5	104.25
Current year	75	152.9
1 year	75	152.9
3 years	27.17	154
5 years	21.7	154
10 years	5.45	154

Manager	Title	Age	Since
Ruchit Mehta CEO	Chief Executive Officer	35	2025-04-15
Utsav Trivedi DFI	Director of Finance/CFO	27	2025-04-15
Aditya Agarwal CMP	Compliance Officer	-	2025-09-11

Director	Title	Age	Since
Simran Ankleshwar Tripathi BRD	Director/Board Member	-	2024-12-30
Ruchit Mehta BRD	Director/Board Member	35	2025-04-15
Simran Utsav Trivedi BRD	Director/Board Member	30	2024-12-30

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STARSOURCE MULTITRADE LIMITED	+0.91%	-16.49%	-33.55%	+138.31%	1.26M
CHURCHILL CAPITAL CORP XI	-0.96%	-6.95%	-	-	806M
DEEP FISSION, INC.	+1.33%	-4.14%	-	-	643M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.10%	-0.20%	-	-	642M
CHURCHILL CAPITAL CORP XII	+0.56%	+0.85%	-	-	611M
CANTOR EQUITY PARTNERS IV, INC.	-0.14%	-0.05%	-	-	596M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.10%	-0.44%	-	-	596M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-1.53%	-1.53%	-	-	575M
CENTIEL AG	-2.80%	+8.17%	+235.34%	-71.49%	563M
Average	-0.31%	-2.31%	+100.90%	+33.41%	559.21M
Weighted average by Cap.	-0.44%	-0.89%	+234.74%	-71.02%

	2024	2025
Net sales	18.38M 191K 167K 154K 142K 267K 273K 1.84M 724K 9M 717K 701K 30.99M	6.2M 64.36K 56.25K 51.9K 47.84K 90.18K 92.18K 620K 244K 3.04M 242K 236K 10.45M
Net income	12M 125K 109K 101K 92.65K 175K 179K 1.2M 473K 5.88M 468K 458K 20.24M	3.42M 35.53K 31.05K 28.66K 26.41K 49.78K 50.89K 343K 135K 1.68M 133K 131K 5.77M
Net Debt	-61.06M -634K -554K -511K -471K -888K -908K -6.11M -2.4M -29.9M -2.38M -2.33M -103M	-106M -1.1M -964K -890K -820K -1.55M -1.58M -10.63M -4.18M -52.03M -4.14M -4.05M -179M